Difference 37726000 exceeds tolerance 17732028.000. Presentation or filing-vintage differences need review.
Parker-Hannifin Corp (PH) reported revenue of $21.50B for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Parker-Hannifin Corp’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Miscellaneous Fabricated Metal Products.
Income
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21.50B | $19.85B | $19.93B | $19.06B | $15.86B | $14.35B | $13.70B | $14.32B | $14.30B | $12.03B |
| Cost of revenue | $13.40B | $12.54B | $12.80B | $12.64B | $10.55B | $9.60B | $10.29B | $10.69B | $10.74B | $9.12B |
| Gross profit | $8.10B | $7.32B | $7.13B | $6.43B | $5.31B | $4.74B | $3.40B | $3.63B | $3.56B | $2.84B |
| Operating income | $5.07B | $4.35B | $4.07B | $3.40B | $2.98B | $2.46B | $1.97B | $2.24B | $2.04B | $1.79B |
| Net income | Unavailable | Unavailable | $2.84B | $2.08B | $1.32B | $1.75B | $1.20B | $1.52B | $1.06B | $983.41M |
| Research & development | $267.00M | $240.00M | $253.00M | $258.00M | $191.00M | $205.00M | $237.00M | $294.85M | $327.88M | $336.68M |
| Weighted-average diluted shares | shares 128.10M | shares 130.20M | shares 130.20M | shares 129.90M | shares 130.36M | shares 130.83M | shares 129.81M | shares 131.78M | shares 135.43M | shares 135.56M |
| Pretax income | $4.56B | $4.11B | $3.60B | $2.68B | $1.61B | $2.25B | $1.51B | $1.95B | $1.70B | $1.33B |
| Income tax expense | $914.00M | $575.00M | $750.00M | $596.00M | $298.04M | $500.10M | $304.52M | $424.39M | $640.96M | $344.80M |
| Diluted EPS | $28.48 | $27.12 | $21.84 | $16.04 | $10.09 | $13.35 | $9.26 | $11.57 | $7.83 | $7.25 |
| Selling, general & administrative | $3.47B | $3.26B | $3.32B | $3.35B | $2.50B | $2.38B | $1.66B | $1.54B | $1.64B | $1.41B |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $501.00M | $467.00M | $422.00M | $475.18M | $535.80M | $733.12M | $685.51M | $3.22B | $822.14M | $884.89M |
| Total assets | $30.88B | $29.49B | $29.30B | $29.96B | $25.94B | $20.34B | $19.89B | $17.73B | $15.32B | $15.49B |
| Current assets | $7.70B | $6.95B | $6.80B | $6.83B | $12.05B | $5.62B | $5.03B | $7.67B | $5.09B | $4.78B |
| Total liabilities | $15.46B | $15.80B | $17.22B | $19.63B | $17.08B | $11.93B | $13.65B | $11.61B | $9.45B | $10.22B |
| Current liabilities | $6.10B | $5.82B | $7.31B | $7.74B | $5.86B | $3.10B | $3.15B | $3.15B | $3.20B | $3.40B |
| Total equity incl. NCI | $15.41B | $13.69B | $12.08B | $10.34B | $8.86B | $8.41B | $6.24B | $6.09B | $5.97B | $5.27B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $3.17B | $2.84B | $2.79B | $2.91B | $2.21B | $2.09B | $1.96B | $1.68B | $1.62B | $1.55B |
| Accounts receivable | $3.17B | $2.91B | $2.87B | Unavailable | Unavailable | Unavailable | Unavailable | $2.13B | $2.15B | $1.93B |
| Goodwill | $11.11B | $10.69B | $10.51B | $10.63B | $7.74B | $8.06B | $7.87B | $5.45B | $5.50B | $5.59B |
| Long-term debt | $6.77B | $7.49B | $7.16B | $8.80B | $9.76B | $6.58B | $7.65B | $6.52B | $4.32B | $4.86B |
| Accounts payable | $2.44B | $2.13B | $1.99B | $2.05B | $1.73B | $1.67B | $1.11B | $1.41B | $1.43B | $1.30B |
Cash flow
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $4.36B | $3.78B | $3.38B | $2.98B | $2.44B | $2.58B | $2.07B | $1.73B | $1.60B | $1.30B |
| Capital expenditures | $459.00M | $435.00M | $400.00M | $381.00M | $230.04M | $209.96M | $232.59M | $195.09M | $247.67M | $203.75M |
| Investing cash flow | -$1.39B | $224.00M | -$298.00M | -$8.18B | -$418.84M | -$13.00K | -$5.02B | -$218.51M | $23.68M | -$3.36B |
| Financing cash flow | -$2.93B | -$3.98B | -$3.12B | -$971.00M | $3.92B | -$2.62B | $449.31M | $902.31M | -$1.68B | $1.78B |
| Net change in cash | $34.00M | $45.00M | -$53.00M | -$6.17B | $5.91B | $47.60M | -$2.53B | $2.40B | -$62.75M | -$336.77M |
| Stock-based compensation | $179.00M | $159.00M | $155.00M | $143.00M | $137.09M | $121.48M | $111.38M | $104.08M | $118.83M | $80.34M |
| Common dividends paid | $936.00M | $861.00M | $782.00M | $704.00M | $569.86M | $475.17M | $453.84M | $412.47M | $365.29M | $345.38M |
| Common share repurchases | $1.26B | $1.77B | $332.00M | $297.00M | $460.06M | $218.82M | $216.05M | $860.05M | $381.04M | $338.08M |
| Depreciation & amortization | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Derived
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $3.90B | $3.34B | $2.98B | $2.60B | $2.21B | $2.37B | $1.84B | $1.54B | $1.35B | $1.10B |
| Gross margin | 37.7% | 36.9% | 35.8% | 33.7% | 33.5% | 33.1% | 24.8% | 25.4% | 24.9% | Unavailable |
| Operating margin | 23.6% | 21.9% | 20.4% | 17.9% | 18.8% | 17.1% | 14.4% | 15.6% | 14.3% | 14.9% |
| FCF margin | 18.2% | 16.8% | 15.0% | 13.6% | 13.9% | 16.5% | 13.4% | 10.7% | 9.4% | 9.1% |
| SBC / revenue | 0.8% | 0.8% | 0.8% | 0.8% | 0.9% | 0.8% | 0.8% | 0.7% | 0.8% | 0.7% |
| Current ratio | 1.26x | 1.19x | 0.93x | 0.88x | 2.06x | 1.81x | 1.60x | 2.43x | 1.59x | 1.41x |
| Revenue YoY growth | 8.3% | -0.4% | 4.5% | 20.2% | 10.6% | 4.8% | -4.4% | 0.1% | 18.9% | Unavailable |
| Net margin | Unavailable | Unavailable | Unavailable | Unavailable | 8.3% | 12.2% | 8.8% | 10.6% | 7.4% | 8.2% |
| R&D / revenue | 1.2% | 1.2% | 1.3% | 1.4% | 1.2% | 1.4% | 1.7% | 2.1% | 2.3% | 2.8% |
| CapEx / revenue | 2.1% | 2.2% | 2.0% | 2.0% | 1.5% | 1.5% | 1.7% | 1.4% | 1.7% | 1.7% |
| Long-term debt / equity | 0.44x | 0.55x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 20.0% | 14.0% | 20.9% | 22.2% | 18.5% | 22.3% | 20.2% | 21.8% | 37.7% | 26.0% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open PH in the interactive workspace to inspect any figure back to its filing.
Source filings
Reconciliation checks needing review
2 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
Difference 105460000 exceeds tolerance 15320087.000. Presentation or filing-vintage differences need review.